Mariana Moscovich

Mariana Moscovich

Auto-generated profile, based on publicly available information

Mariana Moscovich

Department of Neurology, Christian-Albrechts University, Kiel, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2020 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
JGJohanna Geritz
Johanna Geritz
SMSara Maetzold
Sara Maetzold
MSMaren Steffen
Maren Steffen
APAndrea Pilotto
Andrea Pilotto
MCMarta Francisca Corrà
Marta Francisca Corrà
WMWalter Maetzler
Walter Maetzler
Background: Motor and cognitive deficits and consequently mobility problems are common in geriatric patients. The currently available methods for diagnosis and for the evaluation of treatment in this vulnerable cohort are limited. The aims of the ComOn (COgnitive and Motor interactions in the Older populatioN) study are (i) to define quantitative markers with clinical relevance for motor and cognitive deficits, (ii) to investigate the interaction between both motor and cognitive deficits and (iii) to assess health status as well as treatment outcome of 1000 geriatric inpatients in hospitals of Kiel (Germany), Brescia (Italy), Porto (Portugal), Curitiba (Brazil) and Bochum (Germany). Methods: This is a prospective, explorative observational multi-center study. In addition to the comprehensive geriatric assessment, quantitative measures of reduced mobility and motor and cognitive deficits are performed before and after a two week’s inpatient stay. Components of the assessment are mobile technology-based assessments of gait, balance and transfer performance, neuropsychological tests, frailty, sarcopenia, autonomic dysfunction and sensation, and questionnaires to assess behavioral deficits, activities of daily living, quality of life, fear of falling and dysphagia. Structural MRI and an unsupervised 24/7 home assessment of mobility are performed in a subgroup of participants. The study will also investigate the minimal clinically relevant change of the investigated parameters. Discussion: This study will help form a better understanding of symptoms and their complex interactions and treatment effects in a large geriatric cohort.

27 August 2019 in Cerebellum & Ataxias
Verified
Journal Article
Open access
PDF file
AMAdriana Moro
Adriana Moro
MMMariana Moscovich
Mariana Moscovich
MFMarina Farah
Marina Farah
CCCarlos Henrique Camargo
Carlos Henrique Camargo
HTHélio Afonso Ghizoni Teive
Hélio Afonso Ghizoni Teive
RMRenato P. Munhoz
Renato P. Munhoz
Nonmotor symptoms (NMS) have been increasingly recognized in a number of neurodegenerative diseases with a burden of disability that parallels or even surpasses that induced by motor symptoms. As NMS have often been poorly recognized and inadequately treated, much of the most recent developments in the investigation of these disorders has focused on the recognition and quantification of NMS, which will form the basis of improved clinical care for these complex cases. NMS have been only sparsely investigated in a limited number of spinocerebellar ataxias (SCAs), particularly SCA3, and have not been systematically reviewed for other forms of SCAs. The aim of the present study was to review the available literature on the presence of NMS among different types of SCAs.

1 September 2013 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
MMMariana Moscovich
Mariana Moscovich
TMTakashi Morishita
Takashi Morishita
KFKelly D. Foote
Kelly D. Foote
CFChristopher G. Favilla
Christopher G. Favilla
ZCZhongxing Peng Chen
Zhongxing Peng Chen
MOMichael S. Okun
Michael S. Okun

1 December 2020 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
MMMariana Moscovich
Mariana Moscovich
SHSebastian Heinzel
Sebastian Heinzel
RPRonald B. Postuma
Ronald B. Postuma
RRRalf Reilmann
Ralf Reilmann
TKThomas Klockgether
Thomas Klockgether
DBDaniela Berg
Daniela Berg

13 July 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
MMMariana Moscovich
Mariana Moscovich
MLMark Steven LeDoux
Mark Steven LeDoux
JXJianfeng Xiao
Jianfeng Xiao
GRGarrett L Rampon
Garrett L Rampon
SVSatya R Vemula
Satya R Vemula
MOMichael S Okun
Michael S Okun
Dystonia is a movement disorder characterized by involuntary sustained muscle contractions causing twisting and repetitive movements or abnormal postures. Some cases of primary and neurodegenerative dystonia have been associated with mutations in individual genes critical to the G1-S checkpoint pathway (THAP1, ATM, CIZ1 and TAF1). Secondary dystonia is also a relatively common clinical sign in many neurogenetic disorders. However, the contribution of structural variation in the genome to the etiopathogenesis of dystonia remains largely unexplored. Cytogenetic analyses with the Affymetrix Genome-Wide Human SNP Array 6.0 identified a chromosome 13q34 duplication in a 36 year-old female with global developmental delay, facial dysmorphism, tall stature, breast cancer and dystonia, and her neurologically-normal father. Dystonia improved with bilateral globus pallidus interna (GPi) deep brain stimulation (DBS). Genomic breakpoint analysis, quantitative PCR (qPCR) and leukocyte gene expression were used to characterize the structural variant. The 218,345 bp duplication was found to include ADPRHL1, DCUN1D2, and TMCO3, and a 69 bp fragment from a long terminal repeat (LTR) located within Intron 3 of TFDP1. The 3' breakpoint was located within Exon 1 of a TFDP1 long non-coding RNA (NR_026580.1). In the affected subject and her father, gene expression was higher for all three genes located within the duplication. However, in comparison to her father, mother and neurologically-normal controls, the affected subject also showed marked overexpression (2×) of the transcription factor TFDP1 (NM_007111.4). Whole-exome sequencing identified an SGCE variant (c.1295G > A, p.Ser432His) that could possibly have contributed to the development of dystonia in the proband. No pathogenic mutations were identified in BRCA1 or BRCA2. Overexpression of TFDP1 has been associated with breast cancer and may also be linked to the tall stature, dysmorphism and dystonia seen in our patient.

19 June 2018 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
MMMariana Moscovich
Mariana Moscovich
RMRenato Puppi Munhoz
Renato Puppi Munhoz
AMAdriana Moro
Adriana Moro
SRSalmo Raskin
Salmo Raskin
KMKaren McFarland
Karen McFarland
LSLaura Silveira-Moriyama
Laura Silveira-Moriyama